Occult lifelong persistence of infectious hepadnavirus and residual liver inflammation in woodchucks convalescent from acute viral hepatitis.
Traces of hepatitis B virus (HBV) genome can persist for years following recovery from hepatitis B. To determine overall duration, molecular characteristics, and pathological implications of this serologically undetectable form of hepadnaviral carriage, we have analyzed the expression of transcriptionally active virus genomes, their infectivity, and examined liver alterations during the natural lifespan of woodchucks convalescent from acute infection with HBV- related woodchuck hepatitis virus (WHV). In this study, we document lifelong persistence of scanty amounts of replicating virus both in the liver and lymphatic system after spontaneous resolution of an episode of experimental hepadnaviral hepatitis. Antibodies to virus nucleocapsid (core) were found to be the most reliable immunovirological marker coexisting with occult infection. In the majority of convalescent woodchucks, serial liver biopsies showed protracted minimal to mild necroinflammation with periods of normal morphology; however, hepatocellular carcinoma (HCC) ultimately developed in 2 of 9 animals studied. Inocula derived from lymphoid cells of convalescent animals induced classical acute hepatitis in virus-naive woodchucks that progressed to chronic hepatitis and HCC in 1 of the animals, demonstrating infectivity and pathogenic competence of the carried virus. Our results reveal that low levels of infectious WHV and residual hepatic inflammation usually continue for life after resolution of hepatitis and that this recovery does not avert HCC development. They also demonstrate that, in addition to the liver, the lymphatic system is the site of the occult lifelong maintenance of replicating hepadnavirus.
Molecular Virology and Hepatology Research, Division of Basic Medical Sciences, Faculty of Medicine, Health Sciences Centre, Memorial University of Newfoundland, St. John's, Canada. timich@morgan.ucs.mun.ca
T I
TI
Michalak
I U
IU
Pardoe
C S
CS
Coffin
N D
ND
Churchill
D S
DS
Freake
P
P
Smith
C L
CL
Trelegan
D000208:Acute Disease; D000818:Animals; D000914:Antibodies, Viral / Q000032:analysis; D006528:Carcinoma, Hepatocellular / Q000209:etiology; D002908:Chronic Disease; D003289:Convalescence; D005260:Female; D015613:Hepadnaviridae / Q000276:immunology / Q000302:isolation & purification / Q000502:physiology; D018347:Hepadnaviridae Infections; D006520:Hepatitis, Animal / Q000209:etiology / Q000473:pathology; D006524:Hepatitis, Viral, Animal / Q000821:virology*; D008099:Liver / Q000473:pathology / Q000821:virology; D008113:Liver Neoplasms / Q000209:etiology; D008136:Longevity; D008214:Lymphocytes / Q000821:virology; D008297:Male; D008392:Marmota / Q000821:virology*; D019590:Nucleocapsid Proteins / Q000276:immunology; D014779:Virus Replication / Q000502:physiology
D000914:Antibodies, Viral; D019590:Nucleocapsid Proteins